1. Home
  2. NDRA vs UOKA Comparison

NDRA vs UOKA Comparison

Compare NDRA & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDRA
  • UOKA
  • Stock Information
  • Founded
  • NDRA 2007
  • UOKA 2002
  • Country
  • NDRA United States
  • UOKA United Kingdom
  • Employees
  • NDRA N/A
  • UOKA N/A
  • Industry
  • NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • UOKA
  • Sector
  • NDRA Health Care
  • UOKA
  • Exchange
  • NDRA Nasdaq
  • UOKA NYSE
  • Market Cap
  • NDRA 2.3M
  • UOKA 2.7M
  • IPO Year
  • NDRA 2017
  • UOKA N/A
  • Fundamental
  • Price
  • NDRA $3.58
  • UOKA $2.40
  • Analyst Decision
  • NDRA Strong Buy
  • UOKA
  • Analyst Count
  • NDRA 1
  • UOKA 0
  • Target Price
  • NDRA $46.00
  • UOKA N/A
  • AVG Volume (30 Days)
  • NDRA 32.0K
  • UOKA 128.0K
  • Earning Date
  • NDRA 08-13-2025
  • UOKA 08-16-2025
  • Dividend Yield
  • NDRA N/A
  • UOKA N/A
  • EPS Growth
  • NDRA N/A
  • UOKA N/A
  • EPS
  • NDRA N/A
  • UOKA N/A
  • Revenue
  • NDRA N/A
  • UOKA $48,375.00
  • Revenue This Year
  • NDRA N/A
  • UOKA N/A
  • Revenue Next Year
  • NDRA N/A
  • UOKA N/A
  • P/E Ratio
  • NDRA N/A
  • UOKA N/A
  • Revenue Growth
  • NDRA N/A
  • UOKA N/A
  • 52 Week Low
  • NDRA $2.90
  • UOKA $1.98
  • 52 Week High
  • NDRA $197.75
  • UOKA $42.50
  • Technical
  • Relative Strength Index (RSI)
  • NDRA 51.99
  • UOKA N/A
  • Support Level
  • NDRA $3.14
  • UOKA N/A
  • Resistance Level
  • NDRA $3.60
  • UOKA N/A
  • Average True Range (ATR)
  • NDRA 0.20
  • UOKA 0.00
  • MACD
  • NDRA 0.05
  • UOKA 0.00
  • Stochastic Oscillator
  • NDRA 72.13
  • UOKA 0.00

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

About UOKA MDJM LTD

MDJM Ltd is engaged in providing real estate agency services to its real estate developer clients, and provides, on an as-needed basis, real estate consulting services and independent training services. The company generates all of its revenue from Hotel income. The company derives a majority of its revenue from the United Kingdom.

Share on Social Networks: